Defence Therapeutics Inc
CNSX:DTC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Defence Therapeutics Inc
CNSX:DTC
|
CA |
|
B
|
BrilliA Inc
AMEX:BRIA
|
SG |
|
Sembcorp Industries Ltd
SGX:U96
|
SG |
|
I
|
Inta Bina Group Bhd
KLSE:INTA
|
MY |
|
U
|
Universal Robina Corp
XPHS:URC
|
PH |
|
Vcplus Ltd
SGX:43E
|
MY |
|
5
|
5Th Planet Games A/S
OSE:5PG
|
DK |
|
H
|
Hertz Lithium Inc
CNSX:HZ
|
CA |
|
Driven Brands Holdings Inc
NASDAQ:DRVN
|
US |
|
Pacific Resources Ltd
ASX:PXR
|
AU |
|
L
|
Leonardo SpA
XMUN:FMNB
|
IT |
|
T
|
Thu Duc Trading and Import Export JSC
VN:TMC
|
VN |
|
A
|
Altria Group Inc
DUS:PHM7
|
US |
|
Ibiden Co Ltd
TSE:4062
|
JP |
|
Puranium Energy Ltd
OTC:MREYF
|
CA |
Bankruptcy Probability
Defence Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Defence Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
D
|
Defence Therapeutics Inc
CNSX:DTC
|
19.8m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
497.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
230.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
190.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
90.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Defence Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Defence Therapeutics Inc has total debt of 1.6m CAD. This includes both short-term (0 CAD) and long-term (1.6m CAD) debt.
You can find a full breakdown on its Balance Sheet.